221 related articles for article (PubMed ID: 35576899)
41. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
[TBL] [Abstract][Full Text] [Related]
42. Arteriolar C4d in IgA Nephropathy: A Cohort Study.
Faria B; Canão P; Cai Q; Henriques C; Matos AC; Poppelaars F; Gaya da Costa M; Daha MR; Silva R; Pestana M; Seelen MA
Am J Kidney Dis; 2020 Nov; 76(5):669-678. PubMed ID: 32439421
[TBL] [Abstract][Full Text] [Related]
43. Haemoglobin, albumin, lymphocyte, and platelet score as an independent predictor for renal prognosis in IgA nephropathy.
Yuan Y; Liang X; He M; Wu Y; Jiang X
Front Endocrinol (Lausanne); 2024; 15():1339921. PubMed ID: 38737556
[TBL] [Abstract][Full Text] [Related]
44. Renal Megalin mRNA Downregulation Is Associated with CKD Progression in IgA Nephropathy.
Wen L; Wang X; Ji F; Wen J; Zhao Z
Am J Nephrol; 2022; 53(6):481-489. PubMed ID: 35661648
[TBL] [Abstract][Full Text] [Related]
45. Platelet-to-Albumin Ratio: A Novel IgA Nephropathy Prognosis Predictor.
Tan J; Song G; Wang S; Dong L; Liu X; Jiang Z; Qin A; Tang Y; Qin W
Front Immunol; 2022; 13():842362. PubMed ID: 35664006
[TBL] [Abstract][Full Text] [Related]
46. Time series changes in pseudo-R2 values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study.
Kataoka H; Ohara M; Suzuki T; Inoue T; Akanuma T; Kawachi K; Manabe S; Ushio Y; Kawasoe K; Akihisa T; Sato M; Iwasa N; Sawara Y; Honda K; Mochizuki T; Tsuchiya K; Nitta K
PLoS One; 2020; 15(5):e0232885. PubMed ID: 32379841
[TBL] [Abstract][Full Text] [Related]
47. The association of normal-range serum phosphorus with immunoglobulin A nephropathy progression: a retrospective cohort study.
An X; Ding L; Yang Y; Yang Z; Zhang Y; Bai F; Liu L; Shi W; Yang X
Int Urol Nephrol; 2024 Jan; 56(1):275-282. PubMed ID: 37336802
[TBL] [Abstract][Full Text] [Related]
48. The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
[TBL] [Abstract][Full Text] [Related]
49. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study.
Su X; Lv J; Liu Y; Wang J; Ma X; Shi S; Liu L; Zhang H
Am J Kidney Dis; 2017 Aug; 70(2):262-269. PubMed ID: 28320554
[TBL] [Abstract][Full Text] [Related]
50. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
Gong WY; Liu M; Luo D; Liu FN; Yin LH; Li YQ; Zhang J; Peng H
BMC Nephrol; 2019 Apr; 20(1):150. PubMed ID: 31039758
[TBL] [Abstract][Full Text] [Related]
51. [Retrospective Analysis of the Effect of Uric Acid on the Prognosis of Immunoglobulin A Nephropathy With Stage 3-4 Chronic Kidney Disease].
Yu Z; Qin Y; Yuan J; Zhao J; Sun S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Nov; 54(6):1121-1127. PubMed ID: 38162075
[TBL] [Abstract][Full Text] [Related]
52. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
53. Albumin-to-fibrinogen ratio is an independent predictor of corticosteroid response and prognosis in patients with IgA nephropathy.
Zhang Y; Man L
Eur J Med Res; 2023 Apr; 28(1):146. PubMed ID: 37013663
[TBL] [Abstract][Full Text] [Related]
54. Cigarette smoking and progression of IgA nephropathy.
Yamamoto R; Nagasawa Y; Shoji T; Iwatani H; Hamano T; Kawada N; Inoue K; Uehata T; Kaneko T; Okada N; Moriyama T; Horio M; Yamauchi A; Tsubakihara Y; Imai E; Rakugi H; Isaka Y
Am J Kidney Dis; 2010 Aug; 56(2):313-24. PubMed ID: 20471735
[TBL] [Abstract][Full Text] [Related]
55. The association of 5-year therapeutic responsiveness with long-term renal outcome in IgA nephropathy.
Tsushima H; Samejima KI; Eriguchi M; Uemura T; Tasaki H; Fukata F; Nishimoto M; Kosugi T; Tanabe K; Okamoto K; Matsui M; Tsuruya K
Clin Exp Nephrol; 2022 Aug; 26(8):797-807. PubMed ID: 35426595
[TBL] [Abstract][Full Text] [Related]
56. Predictive prognostic value of glomerular C3 deposition in IgA nephropathy.
Xie M; Zhu Y; Wang X; Ren J; Guo H; Huang B; Wang S; Wang P; Liu Y; Liu Y; Zhang J
J Nephrol; 2023 Mar; 36(2):495-505. PubMed ID: 35781866
[TBL] [Abstract][Full Text] [Related]
57. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
58. Prognostic impact of serum bilirubin level on long-term renal survival in IgA nephropathy.
Tanaka S; Ninomiya T; Masutani K; Nagata M; Tsuchimoto A; Tsuruya K; Kitazono T
Clin Exp Nephrol; 2015 Dec; 19(6):1062-70. PubMed ID: 25700934
[TBL] [Abstract][Full Text] [Related]
59. Clinical Significance of Crescent Formation in IgA Nephropathy - a Multicenter Validation Study.
Park S; Baek CH; Park SK; Kang HG; Hyun HS; Park E; Han SH; Ryu DR; Kim DK; Oh KH; Joo KW; Kim YS; Moon KC; Chin HJ; Lee H
Kidney Blood Press Res; 2019; 44(1):22-32. PubMed ID: 30808840
[TBL] [Abstract][Full Text] [Related]
60. Neuroblastoma suppressor of tumorigenicity 1 is associated with the severity of interstitial fibrosis and kidney function decline in IgA nephropathy.
Kobayashi H; Satake E; Murata Y; Otsuka H; Tsunemi A; Azuma M; Nakamura Y; Saito T; Abe M
J Nephrol; 2023 Nov; 36(8):2245-2256. PubMed ID: 37436574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
